UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Quinolines - administration & dosage | Dose-Response Relationship, Drug | Neoplasm Invasiveness - pathology | Adult | Female | Chemotherapy, Adjuvant | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Trastuzumab - adverse effects | Treatment Outcome | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - pathology | Internationality | Survival Analysis | Breast Neoplasms - mortality | Aged | Neoplasm Staging | Quinolines - adverse effects | Antimitotic agents | Tyrosine | Medical colleges | Care and treatment | Adjuvant treatment | Clinical trials | Product development | Breast cancer | Metastasis | College teachers | Antineoplastic agents | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 1, pp. 88 - 96
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Lymph Nodes - pathology | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Breast Neoplasms - drug therapy | Disease-Free Survival | Antibodies, Monoclonal, Humanized - administration & dosage | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - adverse effects | Quinazolines - adverse effects | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Aged | Lapatinib | Neoplasm Staging | Drug-Related Side Effects and Adverse Reactions - classification | Trastuzumab | Antimitotic agents | Product development | Breast cancer | Antineoplastic agents | Adjuvant treatment | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1134 - 1142
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Patient Selection | Poly-ADP-Ribose Binding Proteins | Clinical Trials, Phase III as Topic | Anthracyclines - administration & dosage | Time Factors | Gene Deletion | Female | Chemotherapy, Adjuvant | Precision Medicine | Antigens, Neoplasm - genetics | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Chi-Square Distribution | DNA-Binding Proteins - genetics | Evidence-Based Medicine | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Breast Neoplasms - genetics | Gene Amplification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Breast Neoplasms - mortality | DNA Topoisomerases, Type II - genetics | Biomarkers, Tumor - genetics | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 11/2011, Volume 12, Issue 12, pp. 1101 - 1108
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1101 - 1108
Hematology, Oncology and Palliative Medicine | South America | Triazoles - administration & dosage | Breast Neoplasms - secondary | Humans | North America | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Receptors, Steroid - analysis | Breast Neoplasms - chemistry | Neoplasms, Second Primary | Time Factors | Postmenopause | Female | Aromatase Inhibitors - administration & dosage | Double-Blind Method | Biomarkers, Tumor - analysis | Europe | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Selective Estrogen Receptor Modulators - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Cross-Over Studies | New Zealand | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | South Africa | Australia | Index Medicus
Journal Article
Cancer cell, ISSN 1535-6108, 06/2019, Volume 35, Issue 6, pp. 821 - 822
Journal Article
Acta oncologica, ISSN 0284-186X, 01/2018, Volume 57, Issue 1, pp. 141 - 145
Life Sciences & Biomedicine | Oncology | Science & Technology | Multivariate Analysis | Age Factors | Comorbidity | Humans | Menopause | Middle Aged | Fractures, Bone - epidemiology | Breast Neoplasms - therapy | Denmark - epidemiology | Female | Registries | Aged | Aromatase Inhibitors - therapeutic use | Breast Neoplasms - epidemiology | Cohort Studies | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 02/2017, Volume 23, Issue 4, pp. 946 - 953
Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - classification | Cyclophosphamide - administration & dosage | Prognosis | Receptors, Estrogen - genetics | Levamisole - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols | Receptors, Progesterone - genetics | Breast Neoplasms - drug therapy | Cyclophosphamide - adverse effects | Disease-Free Survival | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - adverse effects | Female | Aged | Levamisole - adverse effects | Immunohistochemistry | Estrogens | Clinical trials | Tissue analysis | Cancer therapies | Confidence intervals | Methotrexate | Invasiveness | Levamisole | Health risks | Data processing | Hazards | Breast cancer | Radiation therapy | Patients | ErbB-2 protein | Cyclophosphamide | Chemotherapy | Statistical models | Experimental design | Medical prognosis | Progesterone | Health risk assessment | Tumors | Cancer | Index Medicus
Journal Article
Clinical epidemiology, ISSN 1179-1349, 10/2016, Volume 8, pp. 445 - 449
Database | Breast cancer | Research | Quality control | Guidelines | Life Sciences & Biomedicine | Public, Environmental & Occupational Health | Science & Technology | Lymphatic system | Mortality | Oncology | Radiation therapy | Patients | Cancer therapies | Studies | Consortia | Pathology | Hospitals | Databases | Microscopy | Womens health | Biopsy | Collaboration | Medical prognosis | Surgery | Mastectomy | Dissection | guidelines | database | quality control | research
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2005, Volume 23, Issue 30, pp. 7483 - 7490
Biological and medical sciences | Medical sciences | Chromosome aberrations | Medical genetics | Tumors | Predictive Value of Tests | Receptor, ErbB-2 - genetics | Stereoisomerism | Humans | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Fluorouracil - therapeutic use | Poly-ADP-Ribose Binding Proteins | Gene Deletion | Female | Retrospective Studies | Chemotherapy, Adjuvant | Antigens, Neoplasm - genetics | Premenopause | Isoenzymes | In Situ Hybridization, Fluorescence | Treatment Outcome | DNA-Binding Proteins - genetics | Breast Neoplasms - drug therapy | Breast Neoplasms - genetics | Gene Amplification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Epirubicin - therapeutic use | DNA Topoisomerases, Type II - genetics | Biomarkers, Tumor - genetics | Index Medicus
Journal Article
British journal of cancer, ISSN 0007-0920, 11/2018, Volume 119, Issue 10, pp. 1297 - 1305
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Risk Factors | Young Adult | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Breast Neoplasms - pathology | Aged, 80 and over | Denmark - epidemiology | Adult | Female | Aged | Breast Neoplasms - chemically induced | Breast Neoplasms - epidemiology | Cohort Studies | Index Medicus
Journal Article
Annals of surgical oncology, ISSN 1068-9265, 12/2015, Volume 22, Issue S3, pp. 476 - 485
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Life Sciences & Biomedicine | Science & Technology | Neoplasm, Residual - pathology | Breast Neoplasms - surgery | Carcinoma, Lobular - pathology | Prognosis | Prospective Studies | Follow-Up Studies | Neoplasm, Residual - surgery | Humans | Middle Aged | Case-Control Studies | Young Adult | Mastectomy | Adult | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Intraductal, Noninfiltrating - surgery | Reoperation | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | Neoplasm Invasiveness | Survival Rate | Neoplasm Recurrence, Local - diagnosis | Carcinoma, Intraductal, Noninfiltrating - pathology | Breast Neoplasms - pathology | Aged | Neoplasm Staging | Second-Look Surgery | Lumpectomy | Relapse | Analysis | Oncology, Experimental | Breast cancer | Research | Cancer | Diseases | Index Medicus
Journal Article